First-in-human Study to Assess the Safety and Pharmacokinetics of LML134 in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
A Phase Ib Dose Escalation Study of the Combination of LEE011 With Letrozole and Dose Expansion of LEE011 With Hormonal Therapy for the Treatment of Pre-(With Goserelin) and Postmenopausal Women With Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
The Efficacy Study of Aclasta on Prosthetic Fixation in Postmenopausal Women After THA
- Status
- WITHDRAWN
- Phase
- PHASE4
Dose Range Finding Study of Bimagrumab in Sarcopenia
- Status
- COMPLETED
- Phase
- PHASE2
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis
- Status
- COMPLETED
- Phase
- N/A
Study of Efficacy and Safety of Omalizumab in Refractory Chronic Spontaneous Urticaria Patients
- Status
- COMPLETED
- Phase
- PHASE3
Change Oxygen Consumption Following Intravitreal Treatment of Lucentis (Ranibizumab) in Eyes With Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- N/A
FGF401 in HCC and Solid Tumors Characterized by Positive FGFR4 and KLB Expression
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Efficacy and Safety of Nivolumab in Combination With EGF816 and of Nivolumab in Combination With INC280 in Patients With Previously Treated Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Everolimus trIal for Advanced prememopausaL Breast Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Reproductive Capacity and Iron Burden in Thalassemia
- Status
- COMPLETED
- Phase
- NA
Long-term Follow-up of Fingolimod Phase II Study Patients
- Status
- COMPLETED
- Phase
- PHASE4
Pilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
A Randomized, Blinded, Placebo-controlled, Phase II Trial of LEE011 in Patients With Relapsed, Refractory, Incurable Teratoma With Recent Progression
- Status
- COMPLETED
- Phase
- PHASE2
Pazopanib as Front-Line Therapy in Patients With Non-Resectable or Metastatic Soft Tissue Sarcomas Who Are Not Candidates for Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Pharmacokinetic and Safety Study of Lower Doses of Ceritinib Taken With a Low-fat Meal Versus 750 mg of Ceritinib in the Fasted State in Adult Patients With (ALK-positive) Metastatic Non-small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE1
ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line Use of Canakinumab
- Status
- COMPLETED
- Phase
- PHASE3
Study of Prophylactic Octreotide to Prevent or Reduce the Frequency and Severity of Diarrhoea in Subjects Receiving Lapatinib With Capecitabine for the Treatment of Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Psoriatic Arthritis
- Status
- COMPLETED
- Phase
- PHASE3
Study of Safety and Efficacy of LEE011 and Ceritinib in Patients With ALK-positive Non-small Cell Lung Cancer.
- Status
- COMPLETED
- Phase
- PHASE1